These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 17047120)

  • 1. Non-invasive evaluation of hepatic fibrosis using magnetic resonance and ultrasound techniques.
    Cobbold JF; Wylezinska M; Cunningham C; Crossey ME; Thomas HC; Cox IJ; Patel N; Taylor-Robinson SD
    Gut; 2006 Nov; 55(11):1670; author reply 1670. PubMed ID: 17047120
    [No Abstract]   [Full Text] [Related]  

  • 2. [The scope of clinical applications of noninvasive methods for the assessment of liver fibrosis results of orginial studies in a multi-field hospital].
    Pavlov ChS; Glushenkov DV; Konovalova ON; Ivashkin VT
    Klin Med (Mosk); 2009; 87(11):40-5. PubMed ID: 20143565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cirrhosis and chronic liver failure: part I. Diagnosis and evaluation.
    Heidelbaugh JJ; Bruderly M
    Am Fam Physician; 2006 Sep; 74(5):756-62. PubMed ID: 16970019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive evaluation of hepatic fibrosis for type C chronic hepatitis.
    Tatsumi C; Kudo M; Ueshima K; Kitai S; Ishikawa E; Yada N; Hagiwara S; Inoue T; Minami Y; Chung H; Maekawa K; Fujimoto K; Kato M; Tonomura A; Mitake T; Shiina T
    Intervirology; 2010; 53(1):76-81. PubMed ID: 20068346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-invasive biomarkers of liver fibrosis in liver transplant patients with hepatitis C: can we avoid liver biopsies?
    Berenguer M
    Dig Liver Dis; 2009 Mar; 41(3):226-8. PubMed ID: 19138576
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non-invasive evaluation of liver fibrosis in hepatitis C].
    de Lédinghen V; Poynard T; Wartelle C; Rosenthal E
    Gastroenterol Clin Biol; 2008 Mar; 32(3 Pt 2):S90-5. PubMed ID: 18675186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Using non-invasive transient elastography for the assessment of hepatic fibrosis].
    Luo JW; Shao JH; Bai J; Cui LG; Wang JR
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):395-7. PubMed ID: 16732926
    [No Abstract]   [Full Text] [Related]  

  • 8. Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy.
    Bedossa P
    Liver Int; 2009 Jan; 29 Suppl 1():19-22. PubMed ID: 19207962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-invasive diagnosis of hepatic fibrosis].
    Lu LG; Zeng MD
    Zhonghua Gan Zang Bing Za Zhi; 2006 Mar; 14(3):210-1. PubMed ID: 16556418
    [No Abstract]   [Full Text] [Related]  

  • 10. Magnetic resonance and ultrasound techniques for the evaluation of hepatic fibrosis.
    Cobbold J; Lim A; Wylezinska M; Cunningham C; Crossey M; Thomas H; Patel N; Cox J; Taylor-Robinson S
    Hepatology; 2006 Jun; 43(6):1401-2; author reply 1402. PubMed ID: 16729323
    [No Abstract]   [Full Text] [Related]  

  • 11. Evolving practices of non-invasive markers of liver fibrosis in patients with chronic hepatitis C in France: time for new guidelines?
    Castera L; Denis J; Babany G; Roudot-Thoraval F
    J Hepatol; 2007 Mar; 46(3):528-9; author reply 529-30. PubMed ID: 17239479
    [No Abstract]   [Full Text] [Related]  

  • 12. [Methods of early diagnostics of hepatic fibrosis and cirrhosis].
    Pavlov ChS; Kogan EA; Shul'pekova IuO; Zolotarevskiĭ VB; Ivashkin VT
    Klin Med (Mosk); 2006; 84(4):53-5. PubMed ID: 16755858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of fibrosis and cirrhosis. Liver biopsy is not always necessary.
    Prescrire Int; 2010 Feb; 19(105):38-42. PubMed ID: 20455345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver biopsy in patients with haemophilia; in search for a reliable, non-invasive alternative.
    Posthouwer D; Mauser-Bunschoten EP; Fischer K
    Haemophilia; 2008 May; 14(3):647-8. PubMed ID: 18282151
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-invasive detection of liver fibrosis in patients with chronic hepatitis C].
    Aiglová K; Ehrmann J; Ehrmann J
    Cas Lek Cesk; 2007; 146(6):542-5. PubMed ID: 17650594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing non-invasive markers for liver fibrosis in clinical practice.
    Sebastiani G; Alberti A
    J Hepatol; 2008 May; 48(5):880-1; author reply 881-3. PubMed ID: 18314216
    [No Abstract]   [Full Text] [Related]  

  • 17. Magnetic resonance imaging in chronic liver disease evaluated in relation to hepatic fibrosis--clinical and experimental results.
    Ohno A; Ohta Y; Ohtomo K; Hirata K; Takatsuki K; Mochida S; Ogata I; Itai Y; Iio M; Fujiwara K
    Radiat Med; 1990; 8(5):159-63. PubMed ID: 2075231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance imaging for quantifying hepatis steatosis and hepatic fibrosis].
    Van Beers B
    Bull Mem Acad R Med Belg; 2009; 164(1-2):44-50; discussion 51-2. PubMed ID: 19718953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent diffusion coefficient measurements with diffusion-weighted magnetic resonance imaging for evaluation of hepatic fibrosis.
    Koinuma M; Ohashi I; Hanafusa K; Shibuya H
    J Magn Reson Imaging; 2005 Jul; 22(1):80-5. PubMed ID: 15971188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
    Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.